Delivery of chimeric hepatitis B core particles into liver cells.

AIMS: To display a liver-specific ligand on the hepatitis B virus core particles for cell-targeting delivery. METHODS AND RESULTS: A liver cell-binding ligand (preS1) was fused at the N-terminal end of the hepatitis B core antigen (HBcAg), but the fusion protein (preS1His(6) HBcAg) was insolu...

Full description

Bibliographic Details
Main Authors: Tan, Wen Siang, Tey, Beng Ti, Ho, Kok Lian, Lee, Khai Wooi
Format: Article
Language:English
English
Published: 2012
Online Access:http://psasir.upm.edu.my/id/eprint/23439/
http://psasir.upm.edu.my/id/eprint/23439/1/Delivery%20of%20chimeric%20hepatitis%20B%20core%20particles%20into%20liver%20cells.pdf
_version_ 1848844757867954176
author Tan, Wen Siang
Tey, Beng Ti
Ho, Kok Lian
Lee, Khai Wooi
author_facet Tan, Wen Siang
Tey, Beng Ti
Ho, Kok Lian
Lee, Khai Wooi
author_sort Tan, Wen Siang
building UPM Institutional Repository
collection Online Access
description AIMS: To display a liver-specific ligand on the hepatitis B virus core particles for cell-targeting delivery. METHODS AND RESULTS: A liver cell-binding ligand (preS1) was fused at the N-terminal end of the hepatitis B core antigen (HBcAg), but the fusion protein (preS1His(6) HBcAg) was insoluble in Escherichia coli and did not form virus-like particles (VLPs). A method to display the preS1 on the HBcAg particle was established by incorporating an appropriate molar ratio of the truncated HBcAg (tHBcAg) to the preS1His(6) HBcAg. Gold immunomicroscopy showed that the subunit mixture reassembled into icosahedral particles, displaying the preS1 ligand on the surface of VLPs. Fluorescence microscopy revealed that the preS1 ligand delivered the fluorescein-labelled VLPs into the HepG2 cells efficiently. CONCLUSIONS: Chimeric VLPs containing the insoluble preS1His(6) HBcAg and highly soluble tHBcAg were produced by a novel incorporation method. The preS1 ligand was exposed on the surface of the VLPs and was shown to deliver fluorescein molecules into liver cells. SIGNIFICANCE AND IMPACT OF STUDY: The newly established incorporation method can be used in the development of chimeric VLPs that could serve as potential nanovehicles to target various cells specifically by substituting the preS1 ligand with different cell-specific ligands.
first_indexed 2025-11-15T08:36:00Z
format Article
id upm-23439
institution Universiti Putra Malaysia
institution_category Local University
language English
English
last_indexed 2025-11-15T08:36:00Z
publishDate 2012
recordtype eprints
repository_type Digital Repository
spelling upm-234392016-01-12T01:38:42Z http://psasir.upm.edu.my/id/eprint/23439/ Delivery of chimeric hepatitis B core particles into liver cells. Tan, Wen Siang Tey, Beng Ti Ho, Kok Lian Lee, Khai Wooi AIMS: To display a liver-specific ligand on the hepatitis B virus core particles for cell-targeting delivery. METHODS AND RESULTS: A liver cell-binding ligand (preS1) was fused at the N-terminal end of the hepatitis B core antigen (HBcAg), but the fusion protein (preS1His(6) HBcAg) was insoluble in Escherichia coli and did not form virus-like particles (VLPs). A method to display the preS1 on the HBcAg particle was established by incorporating an appropriate molar ratio of the truncated HBcAg (tHBcAg) to the preS1His(6) HBcAg. Gold immunomicroscopy showed that the subunit mixture reassembled into icosahedral particles, displaying the preS1 ligand on the surface of VLPs. Fluorescence microscopy revealed that the preS1 ligand delivered the fluorescein-labelled VLPs into the HepG2 cells efficiently. CONCLUSIONS: Chimeric VLPs containing the insoluble preS1His(6) HBcAg and highly soluble tHBcAg were produced by a novel incorporation method. The preS1 ligand was exposed on the surface of the VLPs and was shown to deliver fluorescein molecules into liver cells. SIGNIFICANCE AND IMPACT OF STUDY: The newly established incorporation method can be used in the development of chimeric VLPs that could serve as potential nanovehicles to target various cells specifically by substituting the preS1 ligand with different cell-specific ligands. 2012 Article PeerReviewed application/pdf en http://psasir.upm.edu.my/id/eprint/23439/1/Delivery%20of%20chimeric%20hepatitis%20B%20core%20particles%20into%20liver%20cells.pdf Tan, Wen Siang and Tey, Beng Ti and Ho, Kok Lian and Lee, Khai Wooi (2012) Delivery of chimeric hepatitis B core particles into liver cells. Journal of Applied Microbiology, 112 (1). pp. 119-131. ISSN 1364-5072 10.1111/j.1365-2672.2011.05176.x English
spellingShingle Tan, Wen Siang
Tey, Beng Ti
Ho, Kok Lian
Lee, Khai Wooi
Delivery of chimeric hepatitis B core particles into liver cells.
title Delivery of chimeric hepatitis B core particles into liver cells.
title_full Delivery of chimeric hepatitis B core particles into liver cells.
title_fullStr Delivery of chimeric hepatitis B core particles into liver cells.
title_full_unstemmed Delivery of chimeric hepatitis B core particles into liver cells.
title_short Delivery of chimeric hepatitis B core particles into liver cells.
title_sort delivery of chimeric hepatitis b core particles into liver cells.
url http://psasir.upm.edu.my/id/eprint/23439/
http://psasir.upm.edu.my/id/eprint/23439/
http://psasir.upm.edu.my/id/eprint/23439/1/Delivery%20of%20chimeric%20hepatitis%20B%20core%20particles%20into%20liver%20cells.pdf